59.92
Finanzdaten der Haemonetics Corp-Aktie (HAE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-27 | 2025-09-27 | 2025-06-28 | 2024-09-28 | 2024-06-29 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
3.56%
338.97
|
327.31 | 321.39 | 345.51 | 336.17 |
| Cost Of Revenue |
3.02%
136.58
|
132.57 | 129.15 | 158.07 | 161.25 |
| Gross Profit |
3.92%
202.39
|
194.74 | 192.24 | 187.44 | 174.92 |
|
|
0.93%
134.99
|
136.25 | 138.37 | 135.74 | 135.17 |
| Benefits Costs and Expenses |
1.07%
278.99
|
276.03 | 276.23 | 300.81 | 289.46 |
| Costs And Expenses |
1.07%
278.99
|
276.03 | 276.23 | 300.81 | 289.46 |
| Depreciation and Amortization |
3.08%
27.39
|
28.25 | 28.76 | 29.22 | 29.14 |
| Operating Income/Loss |
15.22%
67.40
|
58.49 | 53.87 | 51.70 | 39.76 |
| Income/Loss From Continuing Operations Before Tax |
16.94%
59.98
|
51.28 | 45.17 | 44.70 | 46.71 |
| Income Tax Expense/Benefit, Deferred |
184.41%
-2.062
|
-0.725 | -3.231 | - | - |
| Income Tax Expense/Benefit |
20.90%
15.23
|
12.60 | 11.14 | 10.87 | 8.34 |
| Income/Loss From Continuing Operations After Tax |
15.66%
44.74
|
38.68 | 34.03 | 33.83 | 38.37 |
|
|
15.66%
44.74
|
38.68 | 34.03 | 33.83 | 38.37 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1.68%
46.79
|
47.59 | 48.11 | 50.90 | 50.94 |
| Diluted Average Shares |
1.42%
46.99
|
47.66 | 48.35 | 51.24 | 51.56 |
| Basic Earnings Per Share |
18.52%
0.96
|
0.81 | 0.71 | 0.66 | 0.75 |
| Diluted Earnings Per Share |
17.28%
0.95
|
0.81 | 0.70 | 0.66 | 0.74 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):